Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model

DOI: 10.7150/thno.26643

Keywords: induced neural stem cells, Parkinson's disease, genomic sequencing, cell therapy, reprogramming

Full-Text   Cite this paper   Add to My Lib

Abstract:

Autologous neural stem cells (NSCs) may offer a promising source for deriving dopaminergic (DA) cells for treatment of Parkinson's disease (PD).

Full-Text